NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/09/2023
Voltar para busca
Dado oficial do USPTO
TAKE2
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
26/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
28/06/2021
Data de registro
26/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/09/2023
Última transação
26/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Hong Kong, HK
Examinador
NADELMAN, ANDREA KOYNER
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Take2 Health Limited
Representantes
Tama L. Drenski RENNER, KENNER, GREIVE, BOBAK, TAYLOR & WEBER
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
DNA screening for scientific research purposes; providing diagnostic services for others in the fields of scienceproviding reagent sample diagnostic services for scientific research purposes and scientific research related thereto; providing reagent sample testing services for others in the fields of science and scientific research related thereto; computer services in the field of pharmaceutical and health care computer productscomputer diagnostic services and computer graphics services; providing an on-line network environment featuring technology that enables users to storeanalyze and share data in the fields of life science; technical support servicestroubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of genetic science and scientific research related thereto; providing temporary use of on-line non-downloadable software for the custom design and ordering of assays and reagents; design and development of computer software for use in analysis of biomolecules relating to diagnosing or screening cancer; design and development of computer software for use in analysis of biomolecules relating to studying genetics and DNA; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to diagnosing or screening cancer; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to studying genetics and DNA; design and development of computer software for use in Software as a Service (SaaS) services for use in genetic and bioinformatics analysis; product development of products used in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnosticsother utilitiesfor use in chemical screening and diagnostic services; product research and development services for others in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research; scientific research services in the nature of chemical screening analysis for scientific research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnosticstherapeuticsherbicidescytotoxic agentsother utilitiesfor use in chemical screening and diagnostic services for others; product researchdevelopment and design of pharmaceutical and health care products; laboratory analysis in the field of nucleic acids and proteinsamong which the analysis of nucleic acids and proteins for detection purposes and monitoringtesting and approving the quality specification of same; medical and scientific research in the field of cancer detection and treatment
Classe 44
Medical services; medical diagnostic testing and reporting services; clinical diagnostic servicespreparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological molecules from human beings or animalsall for medical purposes; genetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/09/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
22/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/08/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
18/07/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
18/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/05/2023
PUBO
PUBLISHED FOR OPPOSITION
23/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/04/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/04/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
28/09/2022
CNSL
SUSPENSION LETTER WRITTEN
28/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/03/2022
GNRT
NON-FINAL ACTION E-MAILED
21/03/2022
CNRT
NON-FINAL ACTION WRITTEN
21/03/2022
DOCK
ASSIGNED TO EXAMINER
18/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2021
NWAP
NEW APPLICATION ENTERED
01/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TAKE2 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.